0001472433-19-000001.txt : 20190725 0001472433-19-000001.hdr.sgml : 20190725 20190725102925 ACCESSION NUMBER: 0001472433-19-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(1) FILED AS OF DATE: 20190725 DATE AS OF CHANGE: 20190725 EFFECTIVENESS DATE: 20190725 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Wyvern Medical Fund LP CENTRAL INDEX KEY: 0001472433 IRS NUMBER: 270897593 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-182341 FILM NUMBER: 19972965 BUSINESS ADDRESS: STREET 1: 111 CENTRAL PARK NORTH STREET 2: SUITE 18A CITY: NEW YORK STATE: NY ZIP: 10026 BUSINESS PHONE: 212-924-3800 MAIL ADDRESS: STREET 1: 111 CENTRAL PARK NORTH STREET 2: SUITE 18A CITY: NEW YORK STATE: NY ZIP: 10026 D/A 1 primary_doc.xml X0708 D/A LIVE 0001472433 Wyvern Medical Fund LP 111 CENTRAL PARK NORTH SUITE 18A NEW YORK NY NEW YORK 10026 212-924-3800 DELAWARE None None Limited Partnership true Brandon Fradd 111 Central Park North Suite 18A New York NY NEW YORK 10026 Executive Officer Managing Member of the Issuer's General Partner. - - Wyvern Medical GP, LLC 111 Central Park North Suite 18A New York NY NEW YORK 10026 Promoter General Partner of the Issuer. Pooled Investment Fund Hedge Fund false Decline to Disclose 06b 3C 3C.1 true 0001472433-18-000001 2009-10-01 true true false 250000 Indefinite 4738205 Indefinite Minimum Investment in Item 11 may be reduced at the discretion of the General Partner. The amount sold and the number of investors on this Form D does not take redemptions and/or withdrawals into consideration. true 2 21 0 0 0 true The person named in Item 3 or affiliates thereof may receive payments deemed to be made from the proceeds of the offering, including management fees and/or performance allocations. The amount of such fees cannot be estimated at this time. false Wyvern Medical Fund LP /Brandon Fradd/ Brandon Fradd Managing Member of the Issuer's General Partner 2019-07-25